Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

Protagenic Therapeutics Inc. (PTIXW)

  • Technical Exchange News
  • June 17, 2025, 19:23 UTC
  • 64
  • 0 comments

NASDAQ traded attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

Comment Full text

Protagenic Therapeutics Inc. (PTIX)

  • Technical Exchange News
  • June 17, 2025, 19:23 UTC
  • 43
  • 0 comments

NASDAQ traded attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

Comment Full text

Clene Inc. (CLNN)

  • Technical Exchange News
  • June 17, 2025, 19:22 UTC
  • 53
  • 0 comments

NASDAQ traded attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

Comment Full text

Clene Inc. (CLNNW)

  • Technical Exchange News
  • June 17, 2025, 19:22 UTC
  • 57
  • 0 comments

NASDAQ traded attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

Comment Full text

AIM ImmunoTech Inc. (AIM)

  • Technical Exchange News
  • June 17, 2025, 07:13 UTC
  • 59
  • 0 comments

NYSE MKT symbol attribute type Test_mode was changed. Previous value: -. New value: N.

Comment Full text

AIM ImmunoTech Inc. (AIM)

  • Technical Exchange News
  • June 17, 2025, 07:13 UTC
  • 56
  • 0 comments

NYSE MKT symbol attribute type Security_Name was changed. Previous value: -. New value: AIM ImmunoTech Inc. Common Stock.

Comment Full text

Lyell Immunopharma (LYEL)

  • Technical Exchange News
  • June 17, 2025, 01:59 UTC
  • 53
  • 0 comments

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

Comment Full text

Lyell Immunopharma (LYEL)

  • Technical Exchange News
  • June 16, 2025, 18:36 UTC
  • 52
  • 0 comments

NASDAQ traded attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

Comment Full text

GlycoMimetics Inc. (GLYC)

  • Technical Exchange News
  • June 16, 2025, 07:40 UTC
  • 51
  • 0 comments

GlycoMimetics Inc. (GLYC) was removed from the list of traded instruments on NASDAQ exchange

Comment Full text

GlycoMimetics Inc. (GLYC)

  • Technical Exchange News
  • June 16, 2025, 07:22 UTC
  • 50
  • 0 comments

NASDAQ symbol attribute type Security_Name was changed. Previous value: GlycoMimetics, Inc. - Common Stock. New value: GlycoMimetics, Inc. - Common Stock.

Comment Full text
  • Previous
  • 200
  • 201
  • 202
  • 203
  • 204
  • Next

Search

News categories

  • Technical Exchange News(11356)
  • Event(2790)
  • SEC News(205104)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(134063)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin